ID

15284

Descripción

Chemoradiation and Tetrathiomolybdate (TM) in Patients With Esophageal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00176800

Link

https://clinicaltrials.gov/show/NCT00176800

Palabras clave

Versiones (1)
  1. 24/5/16 24/5/16 -
Subido en

24 de mayo de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Esophageal Carcinoma NCT00176800

Inglés

Eligibility Esophageal Carcinoma NCT00176800

1 formularios  
Criteria
Descripción

Criteria

1. histologically confirmed adenocarcinoma or squamous cell carcinoma of the esophagus or gastroesophageal junction
Descripción

adenocarcinoma or squamous cell carcinoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001418
UMLS CUI [2]
C0279626
UMLS CUI [3]
C0014871
2. no prior treatment for the esophageal cancer allowed.
Descripción

treatment for the esophageal cance

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0014859
3. no prior thoracic or upper abdominal radiation.
Descripción

thoracic or upper abdominal radiation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0851346
4. disease should be limited to the esophagus and regional lymph nodes. regional lymph nodes are described in section 4.0. however, celiac node enlargement will be acceptable for tumors of the distal esophagus, because they will be included in the radiation field.
Descripción

disease should be limited to the esophagus

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2063953
5. disease must be able to be encompassed in a single radiation field.
Descripción

single radiation field

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1882536
6. no medical contraindication to surgery
Descripción

contraindication to surgery

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0852649
7. all treatment is to be administered at the university of michigan medical center.
Descripción

administered at the university of michigan medical center

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2347790
8. karnofsky performance status > 70 %.
Descripción

karnofsky performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
9. age range: 18 - 75 years old.
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
10. adequate baseline hematopoetic function:
Descripción

hematopoetic function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0018951
platelet count equal to or greater than 100,000/mm3 absolute granulocyte count equal to or greater than 1500/mm3 hematocrit equal to or greater than 29% (patients may be transfused to this level)
Descripción

platelet count

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0005821
UMLS CUI [2]
C0857490
UMLS CUI [3]
C0518014
11. adequate baseline organ function :
Descripción

organ function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678852
creatinine clearance >/= 60 mls/min bilirubin equal to or less than 1.5 x upper limits of normal ast/alt equal to or less than 2.5 x upper limits of normal
Descripción

creatinine clearance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0373595
UMLS CUI [2]
C1557209
UMLS CUI [3]
C0364051
12. patients with any complaint of hearing loss should be evaluated with an audiogram. the average pure tone average hearing loss from 500-2000hz should not exceed 30 db. if it does, the patient should be warned that further hearing loss may be very noticeable and permanent.
Descripción

hearing loss

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3887873
13. prior malignancy is acceptable if the patient is considered to be cured. in most cases this will mean a 5-year disease-free period. contact the principal investigator for any specific question regarding this requirement.
Descripción

prior malignancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
14. patients with active infection, serious inter-current medical conditions are ineligible, according to the judgment of the investigators.
Descripción

active infection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C0009488
15. pregnant or lactating females are not eligible. women of childbearing potential must be using contraception throughout the entire period of treatment.
Descripción

pregnant or lactating women

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
16. ability to give informed consent.
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Volver a la parte superior de la página

Similar models

Eligibility Esophageal Carcinoma NCT00176800

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
adenocarcinoma or squamous cell carcinoma
Item
1. histologically confirmed adenocarcinoma or squamous cell carcinoma of the esophagus or gastroesophageal junction
boolean
C0001418 (UMLS CUI [1])
C0279626 (UMLS CUI [2])
C0014871 (UMLS CUI [3])
treatment for the esophageal cance
Item
2. no prior treatment for the esophageal cancer allowed.
boolean
C0087111 (UMLS CUI [1,1])
C0014859 (UMLS CUI [1,2])
thoracic or upper abdominal radiation
Item
3. no prior thoracic or upper abdominal radiation.
boolean
C0851346 (UMLS CUI [1])
disease should be limited to the esophagus
Item
4. disease should be limited to the esophagus and regional lymph nodes. regional lymph nodes are described in section 4.0. however, celiac node enlargement will be acceptable for tumors of the distal esophagus, because they will be included in the radiation field.
boolean
C2063953 (UMLS CUI [1])
single radiation field
Item
5. disease must be able to be encompassed in a single radiation field.
boolean
C1882536 (UMLS CUI [1])
contraindication to surgery
Item
6. no medical contraindication to surgery
boolean
C0852649 (UMLS CUI [1])
administered at the university of michigan medical center
Item
7. all treatment is to be administered at the university of michigan medical center.
boolean
C2347790 (UMLS CUI [1])
karnofsky performance status
Item
8. karnofsky performance status > 70 %.
boolean
C0206065 (UMLS CUI [1])
age
Item
9. age range: 18 - 75 years old.
boolean
C0001779 (UMLS CUI [1])
hematopoetic function
Item
10. adequate baseline hematopoetic function:
boolean
C0018951 (UMLS CUI [1])
platelet count
Item
platelet count equal to or greater than 100,000/mm3 absolute granulocyte count equal to or greater than 1500/mm3 hematocrit equal to or greater than 29% (patients may be transfused to this level)
boolean
C0005821 (UMLS CUI [1])
C0857490 (UMLS CUI [2])
C0518014 (UMLS CUI [3])
organ function
Item
11. adequate baseline organ function :
boolean
C0678852 (UMLS CUI [1])
creatinine clearance
Item
creatinine clearance >/= 60 mls/min bilirubin equal to or less than 1.5 x upper limits of normal ast/alt equal to or less than 2.5 x upper limits of normal
boolean
C0373595 (UMLS CUI [1])
C1557209 (UMLS CUI [2])
C0364051 (UMLS CUI [3])
hearing loss
Item
12. patients with any complaint of hearing loss should be evaluated with an audiogram. the average pure tone average hearing loss from 500-2000hz should not exceed 30 db. if it does, the patient should be warned that further hearing loss may be very noticeable and permanent.
boolean
C3887873 (UMLS CUI [1])
prior malignancy
Item
13. prior malignancy is acceptable if the patient is considered to be cured. in most cases this will mean a 5-year disease-free period. contact the principal investigator for any specific question regarding this requirement.
boolean
C0006826 (UMLS CUI [1])
active infection
Item
14. patients with active infection, serious inter-current medical conditions are ineligible, according to the judgment of the investigators.
boolean
C0009450 (UMLS CUI [1])
C0009488 (UMLS CUI [2])
pregnant or lactating women
Item
15. pregnant or lactating females are not eligible. women of childbearing potential must be using contraception throughout the entire period of treatment.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
informed consent
Item
16. ability to give informed consent.
boolean
C0021430 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial